Cafcit Articles
CHMP meeting sees good news for AZ, but not for Teva
24 April 2009
APP gets US approval for generic Cafcit
18 February 2008
Mead Johnson to acquire Cafcit
12 May 2003
BI and Roxane receive FDA OK for Cafcit
18 May 2000
US approval of BI's Cafcit for apnea
16 February 2000
Showing 1-5 of 5 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
